NPI: 1992103857 · GADSDEN, AL 35901 · General Acute Care Hospital · NPI assigned 12/09/2014
Authorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
| Authorized Official | DOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL) |
| NPI Enumeration Date | 12/09/2014 |
Other providers sharing the same authorized official: DOAN, CHRISTOPHER
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,351 | $627K |
| 2019 | 21,012 | $581K |
| 2020 | 10,863 | $296K |
| 2021 | 14,009 | $360K |
| 2022 | 18,446 | $549K |
| 2023 | 22,676 | $844K |
| 2024 | 15,299 | $644K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,761 | 8,220 | $2.02M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 12,978 | 11,401 | $700K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,066 | 12,472 | $511K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14,041 | 11,648 | $96K |
| 80053 | Comprehensive metabolic panel | 10,637 | 8,942 | $91K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 289 | 248 | $63K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,923 | 4,867 | $50K |
| 87428 | 968 | 774 | $46K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,537 | 1,671 | $36K |
| 70450 | Computed tomography, head or brain; without contrast material | 431 | 351 | $30K |
| 84484 | 3,636 | 2,592 | $25K | |
| 71045 | Radiologic examination, chest; single view | 5,031 | 4,218 | $22K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,359 | 1,271 | $19K |
| 83690 | 2,704 | 2,306 | $17K | |
| 81001 | 5,032 | 4,325 | $17K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 413 | 351 | $16K |
| 93458 | 53 | 39 | $13K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 331 | 295 | $13K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 159 | 132 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,572 | 1,224 | $11K |
| 87486 | 301 | 260 | $10K | |
| 87581 | 299 | 258 | $10K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 301 | 260 | $10K |
| 81025 | 3,106 | 2,636 | $10K | |
| 87070 | 820 | 754 | $9K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 47 | 40 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 836 | 711 | $7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 134 | 131 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 189 | 173 | $5K |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,525 | 2,003 | $4K |
| 81003 | 1,137 | 982 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,026 | 2,364 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 472 | 353 | $2K |
| 83880 | 88 | 76 | $2K | |
| 85610 | 446 | 384 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 66 | 65 | $962.50 |
| 87081 | 97 | 92 | $869.46 | |
| 71046 | Radiologic examination, chest; 2 views | 109 | 89 | $794.95 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 67 | 57 | $566.16 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,245 | 3,818 | $564.47 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,978 | 3,366 | $486.76 |
| 82553 | 31 | 29 | $417.05 | |
| 80061 | Lipid panel | 46 | 24 | $352.45 |
| 82550 | 31 | 29 | $235.37 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 434 | 328 | $190.18 |
| 85379 | 25 | 25 | $189.99 | |
| 85027 | 94 | 77 | $185.60 | |
| 85730 | 196 | 147 | $169.36 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 105 | 86 | $166.74 |
| 84443 | Thyroid stimulating hormone (TSH) | 14 | 12 | $148.72 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 18 | 12 | $131.05 |
| 83036 | Hemoglobin; glycosylated (A1C) | 14 | 12 | $127.26 |
| 83735 | 17 | 14 | $115.40 | |
| 83605 | 14 | 13 | $78.47 | |
| 82565 | 55 | 41 | $60.48 | |
| 80076 | 13 | 12 | $50.16 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 818 | 664 | $44.02 |
| J1170 | Injection, hydromorphone, up to 4 mg | 16 | 15 | $37.18 |
| 36415 | Collection of venous blood by venipuncture | 2,368 | 1,898 | $18.53 |
| 96361 | Intravenous infusion, hydration; each additional hour | 875 | 729 | $18.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 85 | 74 | $17.65 |
| J1644 | Injection, heparin sodium, per 1000 units | 396 | 210 | $14.14 |
| 96375 | Therapeutic injection; each additional sequential IV push | 986 | 817 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 55 | 50 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 217 | 169 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 226 | 144 | $0.00 |
| 99406 | 29 | 24 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 151 | 117 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 189 | 176 | $0.00 |
| 99152 | 212 | 169 | $0.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 255 | 238 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 264 | 218 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 16 | 15 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 169 | 129 | $0.00 |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | 12 | 12 | $0.00 |